tory in chronic arthritis on account of the erosive effect of the prosthesis on the reamed acetabulum. Cup arthroplasty has also failed to produce consistently good results. The need to replace both surfaces was possibly first appreciated by Philip Wiles who used a stainless steel total hip replacement in about 6 patients in the late 1930s. However, it is only in the last decade that important developments have occurred to enable this method to be more successfully used.
Two important difficulties had to be overcome: the choice of the correct material for the implant, and the finding of a way to ensure that each component remains securely held within bone. Scales (1968, personal communication) showed the superiority of chrome cobalt alloy over other inert all-metal prostheses, such as stainless steel or titanium, in the problem of wear. Chrome cobalt is used in both components of the McKee-Farrar and Ring replacements with only a minimal wear effect, though Parsons et al. (1970) have recently emphasized the importance of careful matching of components if wear and loosening are to be avoided. Since 1959 Charnley has employed the very favourable low friction characteristics of a plastic acetabular cup with a stainless steel femoral head. He is currently using an inert highdensity polythene for the pelvic component.
The problem of fixation has been tackled in two ways. Ring's acetabular prosthesis consists of a cup with a 3 inch (7 5 cm) stem which is screwed up along the weight-bearing lines of the pelvis, between the acetabulum and the sacroiliac joint; the femoral component is a modified Moore's prosthesis. Stability is achieved by following the natural line of weight transmission. The alternative involves the use of methylmethacrylate, an acrylic cement to bond the components to bone, a method first described by Charnley in 1960 and now employed in the Charnley and McKee-Farrar procedures. These techniques have produced greatly improved clinical results. McKee & Watson-Farrar (1966) reported over 90% of patients who were excellent or good up to four years after operation. Ring (1968) gave a figure of 96% and the Charnley procedure seems to give equally impressive results.
The question 'How long will they last?' can only be answered as time passes, but at the moment there would seem to be no cause for despondency; indeed as the methods prove themselves so their application is widening. It is therefore justifiable at the present time to offer the operation to the following groups of patients: (1) Adults of almost any age with two stiff and painful hips. (2) Mr VA R, aged 57 History: In June 1967 he complained of short attacks of severe high epigastric pain; a hard mass found in the left supraclavicular fossa was considered to be malignant and inoperable. Nothing was done at that time. Returned in November 1968 with continued pain, enlargement of the mass, a transient left recurrent laryngeal nerve palsy, weight loss, borborygni, diarrhoea and flushing which often followed meals. Investigations: Biopsy of the lump showed the classical morphology of carcinoid tumour. In January 1969 laparotomy and biopsy showed an irremovable mass of carcinoid tumour around the superior mesenteric vessels. No liver secondaries were detected; there were three small nonobstructive tumours in the lower ileum. Whole blood 5-hydroxytryptamine (5-HT) was 2-3 pg/ml, plasma 5HT 100 ng/ml, urine 5-HT 200 ng/ml. Excretion of 5-hydroxyindole acetic acid (5-HIAA) was measured repeatedly in 24 hour urine collections (Fig 1) . Progress: The superior mesenteric artery was catheterized (Dr D Edwards) and 5-fluorouracil (5-FU) was infused at 10 mg/kg per day and methotrexate at 5 mg/day. There was no immediate clinical improvement and excretion of 5-HIAA continued at high levels. The patient was discharged from hospital on April 5, 1969, and because of continuing symptoms was treated with chlorambucil by mouth-2 mg t.d.s. for 42 days, (Fig 1) . While it is difficult to be objecive about in the symptoms of the carmoid syndrome, the excrtion of 5-HIAA may provide an indication of response to treatnt in this case.
-j o C G said that treatment in this patient a W to be satisfactoy as judged by the excretion of uinary 5-HAA. It was interesting that teric arterial perfusion had not shown much of a reponse thoug. sgiy, on giving the patint chlormbucil, the reducto in 5-HIAA excretion was quite maked and had continued. This had been initially paralleld by improvement in his symptoms but recently tbese ad ten4ed to recur.
He agreed with the cowment that cytotoxic therapy in these circumstances was sometims very debilitating and it was difficult to knmw how effective this therapy was with the smal numbers of cases that had been reported. Thefact that the bloo levels did not change suggested that the urinary excretion results might have been spurious and reprd an interference with metabolm rath than a genuine reduction in secretion by the tumour of 5-HT.
Dr GGr l t _,suggesth that in the carcinoid syndrome, where the main distress was usually from the symptoms caused by the humoral secretions from the tumour, it was worth exploring the possibility that cytotoxic drugs, particularly given by hepatic arterial infusion, might at least diminish the functional activity of the tumour. He was not impressed with the usefulness of infusing 5-fluorouracil into the hepatic artery, and had found the side-effects of the treatment unaccptable. Other cytotoxic drug therapy such as cy1opkos1iamide had given little long-term success.
Intravenous vinbiastine, the molcule of which contained an indole moiety which he had thought might lead to selective concentration by the tumour, had not been effective. 
